ProFem GmbH Report issue

For profit Phase 3
Founded: Vienna Austria (2012)

Organization Overview

First Clinical Trial
2017
NCT03115073
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

ProFem GmbH

Active Ingredients

Drugs in Phase 3 Trials (3)

clotrimazole (Lotrimin) (1 trial)

diclofenac (voltaren) (1 trial)

fluconazole (diflucan) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Candidiasis (Phase 3)

Candidiasis, Vulvovaginal (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 3